nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—ADRB1—stomach cancer	0.419	0.543	CbGaD
Betaxolol—ADRB2—stomach cancer	0.353	0.457	CbGaD
Betaxolol—Practolol—ADRB1—stomach cancer	0.000718	0.0888	CrCbGaD
Betaxolol—Esmolol—ADRB1—stomach cancer	0.000516	0.0638	CrCbGaD
Betaxolol—Atenolol—ADRB1—stomach cancer	0.00045	0.0557	CrCbGaD
Betaxolol—Bisoprolol—ADRB1—stomach cancer	0.000438	0.0543	CrCbGaD
Betaxolol—Esmolol—ADRB2—stomach cancer	0.000434	0.0537	CrCbGaD
Betaxolol—Acebutolol—ADRB1—stomach cancer	0.000415	0.0514	CrCbGaD
Betaxolol—Oxprenolol—ADRB1—stomach cancer	0.000412	0.051	CrCbGaD
Betaxolol—Atenolol—ADRB2—stomach cancer	0.000378	0.0468	CrCbGaD
Betaxolol—Alprenolol—ADRB1—stomach cancer	0.000377	0.0467	CrCbGaD
Betaxolol—Bisoprolol—ADRB2—stomach cancer	0.000369	0.0456	CrCbGaD
Betaxolol—Metoprolol—ADRB1—stomach cancer	0.000351	0.0434	CrCbGaD
Betaxolol—Acebutolol—ADRB2—stomach cancer	0.000349	0.0432	CrCbGaD
Betaxolol—Oxprenolol—ADRB2—stomach cancer	0.000347	0.0429	CrCbGaD
Betaxolol—Alprenolol—HTR1A—stomach cancer	0.000337	0.0418	CrCbGaD
Betaxolol—Pindolol—ADRB1—stomach cancer	0.000324	0.0401	CrCbGaD
Betaxolol—Alprenolol—ADRB2—stomach cancer	0.000317	0.0392	CrCbGaD
Betaxolol—Metoprolol—ADRB2—stomach cancer	0.000295	0.0365	CrCbGaD
Betaxolol—Pindolol—HTR1A—stomach cancer	0.00029	0.0359	CrCbGaD
Betaxolol—Pindolol—ADRB2—stomach cancer	0.000273	0.0338	CrCbGaD
Betaxolol—Chlorphenesin—PTGS2—stomach cancer	0.000203	0.0251	CrCbGaD
Betaxolol—Propranolol—ADRB1—stomach cancer	0.000177	0.0219	CrCbGaD
Betaxolol—Propranolol—HTR1A—stomach cancer	0.000158	0.0196	CrCbGaD
Betaxolol—Propranolol—ADRB2—stomach cancer	0.000149	0.0184	CrCbGaD
Betaxolol—Anorexia—Capecitabine—stomach cancer	0.000112	0.000543	CcSEcCtD
Betaxolol—Angiopathy—Methotrexate—stomach cancer	0.000112	0.000541	CcSEcCtD
Betaxolol—Vomiting—Irinotecan—stomach cancer	0.000112	0.000541	CcSEcCtD
Betaxolol—Sinusitis—Doxorubicin—stomach cancer	0.000112	0.00054	CcSEcCtD
Betaxolol—Immune system disorder—Methotrexate—stomach cancer	0.000111	0.000539	CcSEcCtD
Betaxolol—Dizziness—Fluorouracil—stomach cancer	0.000111	0.000539	CcSEcCtD
Betaxolol—Visual impairment—Epirubicin—stomach cancer	0.000111	0.000538	CcSEcCtD
Betaxolol—Mediastinal disorder—Methotrexate—stomach cancer	0.000111	0.000538	CcSEcCtD
Betaxolol—Agranulocytosis—Doxorubicin—stomach cancer	0.000111	0.000537	CcSEcCtD
Betaxolol—Rash—Irinotecan—stomach cancer	0.000111	0.000536	CcSEcCtD
Betaxolol—Dermatitis—Irinotecan—stomach cancer	0.000111	0.000536	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000111	0.000536	CcSEcCtD
Betaxolol—Chills—Methotrexate—stomach cancer	0.000111	0.000535	CcSEcCtD
Betaxolol—Headache—Irinotecan—stomach cancer	0.00011	0.000533	CcSEcCtD
Betaxolol—Hypotension—Capecitabine—stomach cancer	0.00011	0.000532	CcSEcCtD
Betaxolol—Insomnia—Docetaxel—stomach cancer	0.00011	0.000532	CcSEcCtD
Betaxolol—Paraesthesia—Docetaxel—stomach cancer	0.000109	0.000528	CcSEcCtD
Betaxolol—Alopecia—Methotrexate—stomach cancer	0.000109	0.000527	CcSEcCtD
Betaxolol—Bradycardia—Doxorubicin—stomach cancer	0.000109	0.000526	CcSEcCtD
Betaxolol—Dyspnoea—Docetaxel—stomach cancer	0.000108	0.000524	CcSEcCtD
Betaxolol—Mental disorder—Methotrexate—stomach cancer	0.000108	0.000523	CcSEcCtD
Betaxolol—Eye disorder—Epirubicin—stomach cancer	0.000108	0.000522	CcSEcCtD
Betaxolol—Tinnitus—Epirubicin—stomach cancer	0.000108	0.000521	CcSEcCtD
Betaxolol—Malnutrition—Methotrexate—stomach cancer	0.000107	0.000519	CcSEcCtD
Betaxolol—Erythema—Methotrexate—stomach cancer	0.000107	0.000519	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000107	0.000519	CcSEcCtD
Betaxolol—Flushing—Epirubicin—stomach cancer	0.000107	0.000518	CcSEcCtD
Betaxolol—Cardiac disorder—Epirubicin—stomach cancer	0.000107	0.000518	CcSEcCtD
Betaxolol—Vomiting—Fluorouracil—stomach cancer	0.000107	0.000518	CcSEcCtD
Betaxolol—Rhinitis—Doxorubicin—stomach cancer	0.000107	0.000518	CcSEcCtD
Betaxolol—Dyspepsia—Docetaxel—stomach cancer	0.000107	0.000518	CcSEcCtD
Betaxolol—Insomnia—Capecitabine—stomach cancer	0.000106	0.000515	CcSEcCtD
Betaxolol—Hypoaesthesia—Doxorubicin—stomach cancer	0.000106	0.000514	CcSEcCtD
Betaxolol—Rash—Fluorouracil—stomach cancer	0.000106	0.000514	CcSEcCtD
Betaxolol—Dermatitis—Fluorouracil—stomach cancer	0.000106	0.000513	CcSEcCtD
Betaxolol—Pharyngitis—Doxorubicin—stomach cancer	0.000106	0.000513	CcSEcCtD
Betaxolol—Paraesthesia—Capecitabine—stomach cancer	0.000106	0.000511	CcSEcCtD
Betaxolol—Decreased appetite—Docetaxel—stomach cancer	0.000106	0.000511	CcSEcCtD
Betaxolol—Headache—Fluorouracil—stomach cancer	0.000106	0.00051	CcSEcCtD
Betaxolol—Dysgeusia—Methotrexate—stomach cancer	0.000105	0.000509	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000105	0.000508	CcSEcCtD
Betaxolol—Dyspnoea—Capecitabine—stomach cancer	0.000105	0.000508	CcSEcCtD
Betaxolol—Fatigue—Docetaxel—stomach cancer	0.000105	0.000507	CcSEcCtD
Betaxolol—Angiopathy—Epirubicin—stomach cancer	0.000105	0.000507	CcSEcCtD
Betaxolol—Nausea—Irinotecan—stomach cancer	0.000104	0.000505	CcSEcCtD
Betaxolol—Immune system disorder—Epirubicin—stomach cancer	0.000104	0.000504	CcSEcCtD
Betaxolol—Mediastinal disorder—Epirubicin—stomach cancer	0.000104	0.000503	CcSEcCtD
Betaxolol—Constipation—Docetaxel—stomach cancer	0.000104	0.000503	CcSEcCtD
Betaxolol—Pain—Docetaxel—stomach cancer	0.000104	0.000503	CcSEcCtD
Betaxolol—Dyspepsia—Capecitabine—stomach cancer	0.000104	0.000501	CcSEcCtD
Betaxolol—Chills—Epirubicin—stomach cancer	0.000104	0.000501	CcSEcCtD
Betaxolol—Arrhythmia—Epirubicin—stomach cancer	0.000103	0.000499	CcSEcCtD
Betaxolol—Visual impairment—Doxorubicin—stomach cancer	0.000103	0.000498	CcSEcCtD
Betaxolol—Decreased appetite—Capecitabine—stomach cancer	0.000102	0.000495	CcSEcCtD
Betaxolol—Alopecia—Epirubicin—stomach cancer	0.000102	0.000493	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000102	0.000492	CcSEcCtD
Betaxolol—Fatigue—Capecitabine—stomach cancer	0.000102	0.000491	CcSEcCtD
Betaxolol—Vision blurred—Methotrexate—stomach cancer	0.000101	0.000489	CcSEcCtD
Betaxolol—Mental disorder—Epirubicin—stomach cancer	0.000101	0.000489	CcSEcCtD
Betaxolol—Constipation—Capecitabine—stomach cancer	0.000101	0.000487	CcSEcCtD
Betaxolol—Pain—Capecitabine—stomach cancer	0.000101	0.000487	CcSEcCtD
Betaxolol—Erythema—Epirubicin—stomach cancer	0.000101	0.000486	CcSEcCtD
Betaxolol—Malnutrition—Epirubicin—stomach cancer	0.000101	0.000486	CcSEcCtD
Betaxolol—Feeling abnormal—Docetaxel—stomach cancer	0.0001	0.000485	CcSEcCtD
Betaxolol—Nausea—Fluorouracil—stomach cancer	0.0001	0.000484	CcSEcCtD
Betaxolol—Eye disorder—Doxorubicin—stomach cancer	9.98e-05	0.000483	CcSEcCtD
Betaxolol—Ill-defined disorder—Methotrexate—stomach cancer	9.96e-05	0.000482	CcSEcCtD
Betaxolol—Tinnitus—Doxorubicin—stomach cancer	9.96e-05	0.000482	CcSEcCtD
Betaxolol—Anaemia—Methotrexate—stomach cancer	9.93e-05	0.00048	CcSEcCtD
Betaxolol—Flushing—Doxorubicin—stomach cancer	9.91e-05	0.000479	CcSEcCtD
Betaxolol—Cardiac disorder—Doxorubicin—stomach cancer	9.91e-05	0.000479	CcSEcCtD
Betaxolol—Tension—Epirubicin—stomach cancer	9.86e-05	0.000477	CcSEcCtD
Betaxolol—Dysgeusia—Epirubicin—stomach cancer	9.84e-05	0.000476	CcSEcCtD
Betaxolol—Nervousness—Epirubicin—stomach cancer	9.76e-05	0.000472	CcSEcCtD
Betaxolol—Feeling abnormal—Capecitabine—stomach cancer	9.7e-05	0.000469	CcSEcCtD
Betaxolol—Angiopathy—Doxorubicin—stomach cancer	9.69e-05	0.000469	CcSEcCtD
Betaxolol—Malaise—Methotrexate—stomach cancer	9.68e-05	0.000468	CcSEcCtD
Betaxolol—Muscle spasms—Epirubicin—stomach cancer	9.66e-05	0.000467	CcSEcCtD
Betaxolol—Immune system disorder—Doxorubicin—stomach cancer	9.65e-05	0.000467	CcSEcCtD
Betaxolol—Vertigo—Methotrexate—stomach cancer	9.65e-05	0.000467	CcSEcCtD
Betaxolol—Mediastinal disorder—Doxorubicin—stomach cancer	9.63e-05	0.000466	CcSEcCtD
Betaxolol—Body temperature increased—Docetaxel—stomach cancer	9.61e-05	0.000465	CcSEcCtD
Betaxolol—Chills—Doxorubicin—stomach cancer	9.58e-05	0.000464	CcSEcCtD
Betaxolol—Arrhythmia—Doxorubicin—stomach cancer	9.54e-05	0.000461	CcSEcCtD
Betaxolol—Vision blurred—Epirubicin—stomach cancer	9.47e-05	0.000458	CcSEcCtD
Betaxolol—Alopecia—Doxorubicin—stomach cancer	9.44e-05	0.000456	CcSEcCtD
Betaxolol—Cough—Methotrexate—stomach cancer	9.37e-05	0.000453	CcSEcCtD
Betaxolol—Mental disorder—Doxorubicin—stomach cancer	9.36e-05	0.000453	CcSEcCtD
Betaxolol—Urticaria—Capecitabine—stomach cancer	9.35e-05	0.000452	CcSEcCtD
Betaxolol—Ill-defined disorder—Epirubicin—stomach cancer	9.32e-05	0.000451	CcSEcCtD
Betaxolol—Body temperature increased—Capecitabine—stomach cancer	9.31e-05	0.00045	CcSEcCtD
Betaxolol—Erythema—Doxorubicin—stomach cancer	9.3e-05	0.00045	CcSEcCtD
Betaxolol—Malnutrition—Doxorubicin—stomach cancer	9.3e-05	0.00045	CcSEcCtD
Betaxolol—Anaemia—Epirubicin—stomach cancer	9.29e-05	0.000449	CcSEcCtD
Betaxolol—Myalgia—Methotrexate—stomach cancer	9.14e-05	0.000442	CcSEcCtD
Betaxolol—Chest pain—Methotrexate—stomach cancer	9.14e-05	0.000442	CcSEcCtD
Betaxolol—Arthralgia—Methotrexate—stomach cancer	9.14e-05	0.000442	CcSEcCtD
Betaxolol—Tension—Doxorubicin—stomach cancer	9.13e-05	0.000441	CcSEcCtD
Betaxolol—Dysgeusia—Doxorubicin—stomach cancer	9.11e-05	0.00044	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	9.08e-05	0.000439	CcSEcCtD
Betaxolol—Malaise—Epirubicin—stomach cancer	9.06e-05	0.000438	CcSEcCtD
Betaxolol—Discomfort—Methotrexate—stomach cancer	9.03e-05	0.000437	CcSEcCtD
Betaxolol—Nervousness—Doxorubicin—stomach cancer	9.03e-05	0.000437	CcSEcCtD
Betaxolol—Vertigo—Epirubicin—stomach cancer	9.03e-05	0.000437	CcSEcCtD
Betaxolol—Syncope—Epirubicin—stomach cancer	9.01e-05	0.000436	CcSEcCtD
Betaxolol—Hypersensitivity—Docetaxel—stomach cancer	8.96e-05	0.000433	CcSEcCtD
Betaxolol—Muscle spasms—Doxorubicin—stomach cancer	8.94e-05	0.000432	CcSEcCtD
Betaxolol—Palpitations—Epirubicin—stomach cancer	8.88e-05	0.000429	CcSEcCtD
Betaxolol—Confusional state—Methotrexate—stomach cancer	8.84e-05	0.000427	CcSEcCtD
Betaxolol—Loss of consciousness—Epirubicin—stomach cancer	8.83e-05	0.000427	CcSEcCtD
Betaxolol—Cough—Epirubicin—stomach cancer	8.77e-05	0.000424	CcSEcCtD
Betaxolol—Vision blurred—Doxorubicin—stomach cancer	8.76e-05	0.000424	CcSEcCtD
Betaxolol—Asthenia—Docetaxel—stomach cancer	8.72e-05	0.000422	CcSEcCtD
Betaxolol—Infection—Methotrexate—stomach cancer	8.71e-05	0.000421	CcSEcCtD
Betaxolol—Hypersensitivity—Capecitabine—stomach cancer	8.67e-05	0.000419	CcSEcCtD
Betaxolol—Ill-defined disorder—Doxorubicin—stomach cancer	8.63e-05	0.000417	CcSEcCtD
Betaxolol—Pruritus—Docetaxel—stomach cancer	8.6e-05	0.000416	CcSEcCtD
Betaxolol—Nervous system disorder—Methotrexate—stomach cancer	8.6e-05	0.000416	CcSEcCtD
Betaxolol—Anaemia—Doxorubicin—stomach cancer	8.59e-05	0.000416	CcSEcCtD
Betaxolol—Thrombocytopenia—Methotrexate—stomach cancer	8.58e-05	0.000415	CcSEcCtD
Betaxolol—Myalgia—Epirubicin—stomach cancer	8.56e-05	0.000414	CcSEcCtD
Betaxolol—Chest pain—Epirubicin—stomach cancer	8.56e-05	0.000414	CcSEcCtD
Betaxolol—Arthralgia—Epirubicin—stomach cancer	8.56e-05	0.000414	CcSEcCtD
Betaxolol—Anxiety—Epirubicin—stomach cancer	8.53e-05	0.000412	CcSEcCtD
Betaxolol—Skin disorder—Methotrexate—stomach cancer	8.51e-05	0.000412	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	8.5e-05	0.000411	CcSEcCtD
Betaxolol—Hyperhidrosis—Methotrexate—stomach cancer	8.47e-05	0.00041	CcSEcCtD
Betaxolol—Discomfort—Epirubicin—stomach cancer	8.45e-05	0.000409	CcSEcCtD
Betaxolol—Asthenia—Capecitabine—stomach cancer	8.45e-05	0.000409	CcSEcCtD
Betaxolol—Malaise—Doxorubicin—stomach cancer	8.39e-05	0.000406	CcSEcCtD
Betaxolol—Dry mouth—Epirubicin—stomach cancer	8.37e-05	0.000405	CcSEcCtD
Betaxolol—Vertigo—Doxorubicin—stomach cancer	8.35e-05	0.000404	CcSEcCtD
Betaxolol—Anorexia—Methotrexate—stomach cancer	8.35e-05	0.000404	CcSEcCtD
Betaxolol—Syncope—Doxorubicin—stomach cancer	8.34e-05	0.000403	CcSEcCtD
Betaxolol—Pruritus—Capecitabine—stomach cancer	8.33e-05	0.000403	CcSEcCtD
Betaxolol—Diarrhoea—Docetaxel—stomach cancer	8.32e-05	0.000402	CcSEcCtD
Betaxolol—Confusional state—Epirubicin—stomach cancer	8.27e-05	0.0004	CcSEcCtD
Betaxolol—Palpitations—Doxorubicin—stomach cancer	8.22e-05	0.000397	CcSEcCtD
Betaxolol—Oedema—Epirubicin—stomach cancer	8.2e-05	0.000397	CcSEcCtD
Betaxolol—Hypotension—Methotrexate—stomach cancer	8.19e-05	0.000396	CcSEcCtD
Betaxolol—Loss of consciousness—Doxorubicin—stomach cancer	8.17e-05	0.000395	CcSEcCtD
Betaxolol—Infection—Epirubicin—stomach cancer	8.15e-05	0.000394	CcSEcCtD
Betaxolol—Cough—Doxorubicin—stomach cancer	8.11e-05	0.000392	CcSEcCtD
Betaxolol—Shock—Epirubicin—stomach cancer	8.07e-05	0.00039	CcSEcCtD
Betaxolol—Diarrhoea—Capecitabine—stomach cancer	8.06e-05	0.00039	CcSEcCtD
Betaxolol—Nervous system disorder—Epirubicin—stomach cancer	8.04e-05	0.000389	CcSEcCtD
Betaxolol—Dizziness—Docetaxel—stomach cancer	8.04e-05	0.000389	CcSEcCtD
Betaxolol—Thrombocytopenia—Epirubicin—stomach cancer	8.03e-05	0.000388	CcSEcCtD
Betaxolol—Tachycardia—Epirubicin—stomach cancer	8.01e-05	0.000387	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Methotrexate—stomach cancer	7.99e-05	0.000386	CcSEcCtD
Betaxolol—Skin disorder—Epirubicin—stomach cancer	7.97e-05	0.000385	CcSEcCtD
Betaxolol—Hyperhidrosis—Epirubicin—stomach cancer	7.93e-05	0.000383	CcSEcCtD
Betaxolol—Insomnia—Methotrexate—stomach cancer	7.93e-05	0.000383	CcSEcCtD
Betaxolol—Arthralgia—Doxorubicin—stomach cancer	7.92e-05	0.000383	CcSEcCtD
Betaxolol—Chest pain—Doxorubicin—stomach cancer	7.92e-05	0.000383	CcSEcCtD
Betaxolol—Myalgia—Doxorubicin—stomach cancer	7.92e-05	0.000383	CcSEcCtD
Betaxolol—Anxiety—Doxorubicin—stomach cancer	7.89e-05	0.000382	CcSEcCtD
Betaxolol—Paraesthesia—Methotrexate—stomach cancer	7.87e-05	0.000381	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	7.86e-05	0.00038	CcSEcCtD
Betaxolol—Discomfort—Doxorubicin—stomach cancer	7.82e-05	0.000378	CcSEcCtD
Betaxolol—Anorexia—Epirubicin—stomach cancer	7.82e-05	0.000378	CcSEcCtD
Betaxolol—Dyspnoea—Methotrexate—stomach cancer	7.81e-05	0.000378	CcSEcCtD
Betaxolol—Dizziness—Capecitabine—stomach cancer	7.79e-05	0.000377	CcSEcCtD
Betaxolol—Dry mouth—Doxorubicin—stomach cancer	7.74e-05	0.000374	CcSEcCtD
Betaxolol—Vomiting—Docetaxel—stomach cancer	7.73e-05	0.000374	CcSEcCtD
Betaxolol—Dyspepsia—Methotrexate—stomach cancer	7.72e-05	0.000373	CcSEcCtD
Betaxolol—Rash—Docetaxel—stomach cancer	7.67e-05	0.000371	CcSEcCtD
Betaxolol—Hypotension—Epirubicin—stomach cancer	7.66e-05	0.000371	CcSEcCtD
Betaxolol—Dermatitis—Docetaxel—stomach cancer	7.66e-05	0.00037	CcSEcCtD
Betaxolol—Confusional state—Doxorubicin—stomach cancer	7.65e-05	0.00037	CcSEcCtD
Betaxolol—Decreased appetite—Methotrexate—stomach cancer	7.62e-05	0.000368	CcSEcCtD
Betaxolol—Headache—Docetaxel—stomach cancer	7.62e-05	0.000368	CcSEcCtD
Betaxolol—Oedema—Doxorubicin—stomach cancer	7.59e-05	0.000367	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Methotrexate—stomach cancer	7.57e-05	0.000366	CcSEcCtD
Betaxolol—Fatigue—Methotrexate—stomach cancer	7.56e-05	0.000365	CcSEcCtD
Betaxolol—Infection—Doxorubicin—stomach cancer	7.54e-05	0.000365	CcSEcCtD
Betaxolol—Pain—Methotrexate—stomach cancer	7.5e-05	0.000362	CcSEcCtD
Betaxolol—Vomiting—Capecitabine—stomach cancer	7.49e-05	0.000362	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Epirubicin—stomach cancer	7.47e-05	0.000361	CcSEcCtD
Betaxolol—Shock—Doxorubicin—stomach cancer	7.47e-05	0.000361	CcSEcCtD
Betaxolol—Nervous system disorder—Doxorubicin—stomach cancer	7.44e-05	0.00036	CcSEcCtD
Betaxolol—Thrombocytopenia—Doxorubicin—stomach cancer	7.43e-05	0.000359	CcSEcCtD
Betaxolol—Rash—Capecitabine—stomach cancer	7.42e-05	0.000359	CcSEcCtD
Betaxolol—Insomnia—Epirubicin—stomach cancer	7.42e-05	0.000359	CcSEcCtD
Betaxolol—Dermatitis—Capecitabine—stomach cancer	7.42e-05	0.000359	CcSEcCtD
Betaxolol—Tachycardia—Doxorubicin—stomach cancer	7.41e-05	0.000358	CcSEcCtD
Betaxolol—Headache—Capecitabine—stomach cancer	7.38e-05	0.000357	CcSEcCtD
Betaxolol—Skin disorder—Doxorubicin—stomach cancer	7.37e-05	0.000356	CcSEcCtD
Betaxolol—Paraesthesia—Epirubicin—stomach cancer	7.37e-05	0.000356	CcSEcCtD
Betaxolol—Hyperhidrosis—Doxorubicin—stomach cancer	7.34e-05	0.000355	CcSEcCtD
Betaxolol—Dyspnoea—Epirubicin—stomach cancer	7.31e-05	0.000354	CcSEcCtD
Betaxolol—Anorexia—Doxorubicin—stomach cancer	7.23e-05	0.00035	CcSEcCtD
Betaxolol—Nausea—Docetaxel—stomach cancer	7.22e-05	0.000349	CcSEcCtD
Betaxolol—Feeling abnormal—Methotrexate—stomach cancer	7.22e-05	0.000349	CcSEcCtD
Betaxolol—Dyspepsia—Epirubicin—stomach cancer	7.22e-05	0.000349	CcSEcCtD
Betaxolol—Decreased appetite—Epirubicin—stomach cancer	7.13e-05	0.000345	CcSEcCtD
Betaxolol—Hypotension—Doxorubicin—stomach cancer	7.09e-05	0.000343	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Epirubicin—stomach cancer	7.08e-05	0.000342	CcSEcCtD
Betaxolol—Fatigue—Epirubicin—stomach cancer	7.07e-05	0.000342	CcSEcCtD
Betaxolol—Pain—Epirubicin—stomach cancer	7.01e-05	0.000339	CcSEcCtD
Betaxolol—Constipation—Epirubicin—stomach cancer	7.01e-05	0.000339	CcSEcCtD
Betaxolol—Nausea—Capecitabine—stomach cancer	6.99e-05	0.000338	CcSEcCtD
Betaxolol—Urticaria—Methotrexate—stomach cancer	6.96e-05	0.000337	CcSEcCtD
Betaxolol—Body temperature increased—Methotrexate—stomach cancer	6.93e-05	0.000335	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Doxorubicin—stomach cancer	6.91e-05	0.000334	CcSEcCtD
Betaxolol—Insomnia—Doxorubicin—stomach cancer	6.86e-05	0.000332	CcSEcCtD
Betaxolol—Paraesthesia—Doxorubicin—stomach cancer	6.81e-05	0.00033	CcSEcCtD
Betaxolol—Dyspnoea—Doxorubicin—stomach cancer	6.77e-05	0.000327	CcSEcCtD
Betaxolol—Feeling abnormal—Epirubicin—stomach cancer	6.76e-05	0.000327	CcSEcCtD
Betaxolol—Dyspepsia—Doxorubicin—stomach cancer	6.68e-05	0.000323	CcSEcCtD
Betaxolol—Decreased appetite—Doxorubicin—stomach cancer	6.6e-05	0.000319	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Doxorubicin—stomach cancer	6.55e-05	0.000317	CcSEcCtD
Betaxolol—Fatigue—Doxorubicin—stomach cancer	6.54e-05	0.000316	CcSEcCtD
Betaxolol—Urticaria—Epirubicin—stomach cancer	6.52e-05	0.000315	CcSEcCtD
Betaxolol—Pain—Doxorubicin—stomach cancer	6.49e-05	0.000314	CcSEcCtD
Betaxolol—Constipation—Doxorubicin—stomach cancer	6.49e-05	0.000314	CcSEcCtD
Betaxolol—Body temperature increased—Epirubicin—stomach cancer	6.48e-05	0.000314	CcSEcCtD
Betaxolol—Hypersensitivity—Methotrexate—stomach cancer	6.46e-05	0.000312	CcSEcCtD
Betaxolol—Asthenia—Methotrexate—stomach cancer	6.29e-05	0.000304	CcSEcCtD
Betaxolol—Feeling abnormal—Doxorubicin—stomach cancer	6.25e-05	0.000302	CcSEcCtD
Betaxolol—Pruritus—Methotrexate—stomach cancer	6.2e-05	0.0003	CcSEcCtD
Betaxolol—Hypersensitivity—Epirubicin—stomach cancer	6.04e-05	0.000292	CcSEcCtD
Betaxolol—Urticaria—Doxorubicin—stomach cancer	6.03e-05	0.000292	CcSEcCtD
Betaxolol—Body temperature increased—Doxorubicin—stomach cancer	6e-05	0.00029	CcSEcCtD
Betaxolol—Diarrhoea—Methotrexate—stomach cancer	6e-05	0.00029	CcSEcCtD
Betaxolol—Asthenia—Epirubicin—stomach cancer	5.88e-05	0.000285	CcSEcCtD
Betaxolol—Pruritus—Epirubicin—stomach cancer	5.8e-05	0.000281	CcSEcCtD
Betaxolol—Dizziness—Methotrexate—stomach cancer	5.8e-05	0.00028	CcSEcCtD
Betaxolol—Diarrhoea—Epirubicin—stomach cancer	5.61e-05	0.000271	CcSEcCtD
Betaxolol—Hypersensitivity—Doxorubicin—stomach cancer	5.59e-05	0.00027	CcSEcCtD
Betaxolol—Vomiting—Methotrexate—stomach cancer	5.57e-05	0.000269	CcSEcCtD
Betaxolol—Rash—Methotrexate—stomach cancer	5.53e-05	0.000267	CcSEcCtD
Betaxolol—Dermatitis—Methotrexate—stomach cancer	5.52e-05	0.000267	CcSEcCtD
Betaxolol—Headache—Methotrexate—stomach cancer	5.49e-05	0.000266	CcSEcCtD
Betaxolol—Asthenia—Doxorubicin—stomach cancer	5.45e-05	0.000263	CcSEcCtD
Betaxolol—Dizziness—Epirubicin—stomach cancer	5.42e-05	0.000262	CcSEcCtD
Betaxolol—Pruritus—Doxorubicin—stomach cancer	5.37e-05	0.00026	CcSEcCtD
Betaxolol—Vomiting—Epirubicin—stomach cancer	5.22e-05	0.000252	CcSEcCtD
Betaxolol—Nausea—Methotrexate—stomach cancer	5.21e-05	0.000252	CcSEcCtD
Betaxolol—Diarrhoea—Doxorubicin—stomach cancer	5.19e-05	0.000251	CcSEcCtD
Betaxolol—Rash—Epirubicin—stomach cancer	5.17e-05	0.00025	CcSEcCtD
Betaxolol—Dermatitis—Epirubicin—stomach cancer	5.17e-05	0.00025	CcSEcCtD
Betaxolol—Headache—Epirubicin—stomach cancer	5.14e-05	0.000248	CcSEcCtD
Betaxolol—Dizziness—Doxorubicin—stomach cancer	5.02e-05	0.000243	CcSEcCtD
Betaxolol—Nausea—Epirubicin—stomach cancer	4.87e-05	0.000236	CcSEcCtD
Betaxolol—Vomiting—Doxorubicin—stomach cancer	4.83e-05	0.000233	CcSEcCtD
Betaxolol—Rash—Doxorubicin—stomach cancer	4.79e-05	0.000231	CcSEcCtD
Betaxolol—Dermatitis—Doxorubicin—stomach cancer	4.78e-05	0.000231	CcSEcCtD
Betaxolol—Headache—Doxorubicin—stomach cancer	4.75e-05	0.00023	CcSEcCtD
Betaxolol—Nausea—Doxorubicin—stomach cancer	4.51e-05	0.000218	CcSEcCtD
Betaxolol—ADRB1—Signaling Pathways—PRKAB1—stomach cancer	1.36e-05	0.00103	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—ANXA1—stomach cancer	1.34e-05	0.00102	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NDUFV1—stomach cancer	1.34e-05	0.00101	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NDUFS1—stomach cancer	1.34e-05	0.00101	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GMPR2—stomach cancer	1.33e-05	0.00101	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PRKAB1—stomach cancer	1.33e-05	0.00101	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—ANXA1—stomach cancer	1.32e-05	0.000996	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—RNF43—stomach cancer	1.31e-05	0.000993	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—KISS1—stomach cancer	1.31e-05	0.000993	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	1.3e-05	0.000987	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	1.29e-05	0.000974	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—KISS1—stomach cancer	1.28e-05	0.000971	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—RNF43—stomach cancer	1.28e-05	0.000971	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	1.28e-05	0.000966	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—ADRB1—stomach cancer	1.27e-05	0.000964	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—RORA—stomach cancer	1.27e-05	0.000962	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SUCLG1—stomach cancer	1.22e-05	0.000923	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—IDH3B—stomach cancer	1.22e-05	0.000923	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PGLS—stomach cancer	1.19e-05	0.000902	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—BLVRB—stomach cancer	1.19e-05	0.000902	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FST—stomach cancer	1.17e-05	0.000885	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—ADRB2—stomach cancer	1.16e-05	0.00088	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—HBEGF—stomach cancer	1.14e-05	0.000866	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FST—stomach cancer	1.14e-05	0.000865	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PPAP2A—stomach cancer	1.14e-05	0.000861	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NDUFV1—stomach cancer	1.13e-05	0.000858	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NDUFS1—stomach cancer	1.13e-05	0.000858	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GAST—stomach cancer	1.13e-05	0.000854	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—RGS2—stomach cancer	1.13e-05	0.000854	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—HBEGF—stomach cancer	1.12e-05	0.000847	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	1.11e-05	0.000838	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GAST—stomach cancer	1.1e-05	0.000835	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—RGS2—stomach cancer	1.1e-05	0.000835	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FGG—stomach cancer	1.07e-05	0.000809	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—ADRB2—stomach cancer	1.06e-05	0.000799	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FGG—stomach cancer	1.05e-05	0.000792	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PPP2R1A—stomach cancer	1.03e-05	0.000783	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PRKAA1—stomach cancer	1.03e-05	0.000779	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CA1—stomach cancer	1.01e-05	0.000767	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CKB—stomach cancer	1.01e-05	0.000767	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—FBP1—stomach cancer	1.01e-05	0.000767	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NDUFA2—stomach cancer	1.01e-05	0.000767	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PPP2R1A—stomach cancer	1.01e-05	0.000766	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—BLVRB—stomach cancer	1.01e-05	0.000765	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PGLS—stomach cancer	1.01e-05	0.000765	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PRKAA1—stomach cancer	1.01e-05	0.000762	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—RBP4—stomach cancer	9.93e-06	0.000752	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—CXCL8—stomach cancer	9.93e-06	0.000752	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—RBP4—stomach cancer	9.72e-06	0.000736	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—CXCL8—stomach cancer	9.71e-06	0.000735	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PPAP2A—stomach cancer	9.63e-06	0.000729	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PLIN2—stomach cancer	9.53e-06	0.000721	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CA2—stomach cancer	9.27e-06	0.000702	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	9.26e-06	0.000701	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NT5E—stomach cancer	9.03e-06	0.000684	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PGAM1—stomach cancer	9.03e-06	0.000684	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ALDH7A1—stomach cancer	8.62e-06	0.000652	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PLCE1—stomach cancer	8.62e-06	0.000652	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NDUFA2—stomach cancer	8.59e-06	0.00065	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CKB—stomach cancer	8.59e-06	0.00065	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—FBP1—stomach cancer	8.59e-06	0.00065	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CA1—stomach cancer	8.59e-06	0.00065	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HSPB1—stomach cancer	8.54e-06	0.000647	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AGTR2—stomach cancer	8.54e-06	0.000647	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—BMP2—stomach cancer	8.45e-06	0.00064	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—F2R—stomach cancer	8.45e-06	0.00064	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AGTR2—stomach cancer	8.36e-06	0.000633	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HSPB1—stomach cancer	8.36e-06	0.000633	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AKR1C3—stomach cancer	8.31e-06	0.000629	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—F2R—stomach cancer	8.26e-06	0.000626	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—BMP2—stomach cancer	8.26e-06	0.000626	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—UMPS—stomach cancer	8.26e-06	0.000626	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HTR1A—stomach cancer	8.22e-06	0.000623	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AKR1C3—stomach cancer	8.13e-06	0.000616	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PLIN2—stomach cancer	8.07e-06	0.000611	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HTR1A—stomach cancer	8.04e-06	0.000609	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—PRKCB—stomach cancer	7.96e-06	0.000603	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ANXA1—stomach cancer	7.94e-06	0.000601	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CA2—stomach cancer	7.85e-06	0.000595	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—PRKCB—stomach cancer	7.79e-06	0.00059	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ANXA1—stomach cancer	7.77e-06	0.000588	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ECHS1—stomach cancer	7.68e-06	0.000582	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PDHA1—stomach cancer	7.68e-06	0.000582	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NT5E—stomach cancer	7.65e-06	0.000579	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PGAM1—stomach cancer	7.65e-06	0.000579	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ADRB1—stomach cancer	7.52e-06	0.00057	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—RPS6—stomach cancer	7.35e-06	0.000556	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PLCE1—stomach cancer	7.3e-06	0.000553	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ALDH7A1—stomach cancer	7.3e-06	0.000553	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PRKCB—stomach cancer	7.23e-06	0.000548	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—TYMP—stomach cancer	7.22e-06	0.000547	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—FADS1—stomach cancer	7.22e-06	0.000547	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—IL6ST—stomach cancer	7.2e-06	0.000545	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—RPS6—stomach cancer	7.19e-06	0.000544	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PRKCB—stomach cancer	7.07e-06	0.000536	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—IL6ST—stomach cancer	7.05e-06	0.000533	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—UMPS—stomach cancer	7e-06	0.00053	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SREBF2—stomach cancer	6.76e-06	0.000512	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HBEGF—stomach cancer	6.75e-06	0.000511	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—RORA—stomach cancer	6.68e-06	0.000506	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HBEGF—stomach cancer	6.61e-06	0.0005	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PDHA1—stomach cancer	6.51e-06	0.000493	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ECHS1—stomach cancer	6.51e-06	0.000493	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—IL6R—stomach cancer	6.43e-06	0.000487	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—RHOA—stomach cancer	6.39e-06	0.000484	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—IL6R—stomach cancer	6.29e-06	0.000476	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ALDOB—stomach cancer	6.26e-06	0.000474	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—RHOA—stomach cancer	6.25e-06	0.000473	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ADRB2—stomach cancer	6.23e-06	0.000472	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—FADS1—stomach cancer	6.12e-06	0.000463	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—TYMP—stomach cancer	6.12e-06	0.000463	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PPP2R1A—stomach cancer	6.11e-06	0.000462	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PPP2R1A—stomach cancer	5.97e-06	0.000452	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ALOX5—stomach cancer	5.82e-06	0.000441	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—RHOA—stomach cancer	5.8e-06	0.000439	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SREBF2—stomach cancer	5.73e-06	0.000434	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—DPYD—stomach cancer	5.73e-06	0.000434	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—RHOA—stomach cancer	5.68e-06	0.00043	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—SMAD4—stomach cancer	5.67e-06	0.000429	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—RORA—stomach cancer	5.66e-06	0.000429	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—CXCL8—stomach cancer	5.61e-06	0.000425	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SMAD4—stomach cancer	5.55e-06	0.00042	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—CXCL8—stomach cancer	5.49e-06	0.000416	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FYN—stomach cancer	5.38e-06	0.000408	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ALDOB—stomach cancer	5.3e-06	0.000402	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FYN—stomach cancer	5.27e-06	0.000399	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—CXCL8—stomach cancer	5.1e-06	0.000386	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GSTT1—stomach cancer	5.06e-06	0.000383	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FGFR2—stomach cancer	5.05e-06	0.000383	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYP2A6—stomach cancer	5.01e-06	0.000379	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	5e-06	0.000379	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	4.99e-06	0.000378	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—CXCL8—stomach cancer	4.98e-06	0.000377	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FGFR2—stomach cancer	4.94e-06	0.000374	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ALOX5—stomach cancer	4.93e-06	0.000373	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—AKR1C3—stomach cancer	4.87e-06	0.000369	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—DPYD—stomach cancer	4.85e-06	0.000367	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ENO1—stomach cancer	4.74e-06	0.000359	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IRS2—stomach cancer	4.63e-06	0.00035	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IRS2—stomach cancer	4.53e-06	0.000343	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CAV1—stomach cancer	4.49e-06	0.00034	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APOA1—stomach cancer	4.48e-06	0.000339	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	4.4e-06	0.000333	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CAV1—stomach cancer	4.39e-06	0.000332	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APOA1—stomach cancer	4.38e-06	0.000332	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GSTT1—stomach cancer	4.29e-06	0.000325	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PRKCB—stomach cancer	4.27e-06	0.000323	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IL6ST—stomach cancer	4.25e-06	0.000322	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP2A6—stomach cancer	4.24e-06	0.000321	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CD44—stomach cancer	4.21e-06	0.000319	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PRKCB—stomach cancer	4.18e-06	0.000316	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IL6ST—stomach cancer	4.16e-06	0.000315	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—AKR1C3—stomach cancer	4.12e-06	0.000312	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APC—stomach cancer	4.09e-06	0.00031	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ENO1—stomach cancer	4.02e-06	0.000304	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APC—stomach cancer	4e-06	0.000303	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.95e-06	0.000299	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—MAPK3—stomach cancer	3.91e-06	0.000296	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—MAPK3—stomach cancer	3.83e-06	0.00029	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IL6R—stomach cancer	3.8e-06	0.000287	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—MAPK1—stomach cancer	3.73e-06	0.000282	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—EGFR—stomach cancer	3.72e-06	0.000282	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IL6R—stomach cancer	3.71e-06	0.000281	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—MAPK1—stomach cancer	3.64e-06	0.000276	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—EGFR—stomach cancer	3.64e-06	0.000276	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PPP2R1A—stomach cancer	3.58e-06	0.000271	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CD44—stomach cancer	3.56e-06	0.00027	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—PIK3CA—stomach cancer	3.56e-06	0.00027	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—SERPINE1—stomach cancer	3.55e-06	0.000269	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—KRAS—stomach cancer	3.52e-06	0.000266	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GSTP1—stomach cancer	3.51e-06	0.000266	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—PIK3CA—stomach cancer	3.48e-06	0.000264	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SERPINE1—stomach cancer	3.48e-06	0.000263	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HMOX1—stomach cancer	3.46e-06	0.000262	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	3.46e-06	0.000262	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—KRAS—stomach cancer	3.44e-06	0.000261	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—RHOA—stomach cancer	3.43e-06	0.00026	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NOS3—stomach cancer	3.39e-06	0.000257	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—RHOA—stomach cancer	3.35e-06	0.000254	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NOS3—stomach cancer	3.32e-06	0.000251	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—TYMS—stomach cancer	3.26e-06	0.000247	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PIK3CA—stomach cancer	3.23e-06	0.000245	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GSTM1—stomach cancer	3.23e-06	0.000244	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ERBB2—stomach cancer	3.17e-06	0.00024	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PIK3CA—stomach cancer	3.16e-06	0.000239	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ERBB2—stomach cancer	3.1e-06	0.000235	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ERCC2—stomach cancer	3.03e-06	0.00023	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PPP2R1A—stomach cancer	3.03e-06	0.00023	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CXCL8—stomach cancer	3.01e-06	0.000228	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—HRAS—stomach cancer	2.99e-06	0.000226	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GSTP1—stomach cancer	2.97e-06	0.000225	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CXCL8—stomach cancer	2.94e-06	0.000223	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CDKN1B—stomach cancer	2.94e-06	0.000223	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HMOX1—stomach cancer	2.93e-06	0.000222	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—HRAS—stomach cancer	2.93e-06	0.000222	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CDKN1B—stomach cancer	2.88e-06	0.000218	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—IL6—stomach cancer	2.86e-06	0.000217	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—MTHFR—stomach cancer	2.85e-06	0.000216	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CCND1—stomach cancer	2.8e-06	0.000212	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—IL6—stomach cancer	2.8e-06	0.000212	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—JUN—stomach cancer	2.8e-06	0.000212	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—TYMS—stomach cancer	2.76e-06	0.000209	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CCND1—stomach cancer	2.74e-06	0.000208	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—JUN—stomach cancer	2.74e-06	0.000207	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GSTM1—stomach cancer	2.73e-06	0.000207	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MMP9—stomach cancer	2.72e-06	0.000206	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CDKN1A—stomach cancer	2.71e-06	0.000205	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MMP9—stomach cancer	2.66e-06	0.000202	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CDKN1A—stomach cancer	2.65e-06	0.000201	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MAPK8—stomach cancer	2.65e-06	0.0002	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CAV1—stomach cancer	2.63e-06	0.000199	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOA1—stomach cancer	2.62e-06	0.000199	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MAPK8—stomach cancer	2.59e-06	0.000196	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ERCC2—stomach cancer	2.57e-06	0.000195	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—VEGFA—stomach cancer	2.44e-06	0.000185	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—STAT3—stomach cancer	2.42e-06	0.000183	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—MTHFR—stomach cancer	2.41e-06	0.000183	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—VEGFA—stomach cancer	2.39e-06	0.000181	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—STAT3—stomach cancer	2.37e-06	0.000179	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MAPK3—stomach cancer	2.31e-06	0.000175	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PPARG—stomach cancer	2.31e-06	0.000175	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MAPK3—stomach cancer	2.26e-06	0.000171	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MYC—stomach cancer	2.25e-06	0.00017	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CAV1—stomach cancer	2.23e-06	0.000169	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOA1—stomach cancer	2.22e-06	0.000168	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MAPK1—stomach cancer	2.2e-06	0.000167	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MYC—stomach cancer	2.2e-06	0.000167	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—EGFR—stomach cancer	2.2e-06	0.000167	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MAPK1—stomach cancer	2.15e-06	0.000163	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—EGFR—stomach cancer	2.15e-06	0.000163	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.13e-06	0.000161	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—KRAS—stomach cancer	2.08e-06	0.000157	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ALB—stomach cancer	2.08e-06	0.000157	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—KRAS—stomach cancer	2.03e-06	0.000154	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NOS3—stomach cancer	1.99e-06	0.000151	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PPARG—stomach cancer	1.96e-06	0.000148	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PIK3CA—stomach cancer	1.91e-06	0.000145	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PIK3CA—stomach cancer	1.87e-06	0.000141	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TP53—stomach cancer	1.85e-06	0.00014	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PTGS2—stomach cancer	1.82e-06	0.000138	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TP53—stomach cancer	1.81e-06	0.000137	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HRAS—stomach cancer	1.77e-06	0.000134	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ALB—stomach cancer	1.76e-06	0.000133	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HRAS—stomach cancer	1.73e-06	0.000131	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IL6—stomach cancer	1.69e-06	0.000128	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NOS3—stomach cancer	1.68e-06	0.000128	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IL6—stomach cancer	1.65e-06	0.000125	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PTGS2—stomach cancer	1.54e-06	0.000117	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.12e-06	8.47e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PIK3CA—stomach cancer	9.48e-07	7.18e-05	CbGpPWpGaD
